IMUNON Reports Interim Progression-Free Survival and Overall Survival Data in Phase 1/2 OVATION 2 Study in Advanced Ovarian CancerGlobeNewsWire • 09/28/23
IMUNON Releases Enterprise Video Highlighting the Company's Mission, Vision, Values, Breakthroughs and TechnologiesGlobeNewsWire • 09/26/23
IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa VirusGlobeNewsWire • 08/24/23
IMUNON Expands Scientific Advisory Board with the Addition of Dr. Sachet ShuklaGlobeNewsWire • 08/14/23
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/23
Preclinical Data Showing Strong Immunogenicity and Protection with IMUNON's PlaCCine DNA-Based Vaccines Modality Available Online on bioRxivGlobeNewsWire • 08/07/23
IMUNON to Hold Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 10, 2023GlobeNewsWire • 08/03/23
IMUNON Unveils New Manufacturing Capabilities at Huntsville's HudsonAlpha Biotech CampusGlobeNewsWire • 06/27/23
IMUNON CEO to Discuss Company's Novel Non-viral DNA Therapy Option at the Mass General Brigham World Medical Innovation Forum 2023GlobeNewsWire • 06/12/23
IMUNON's CEO Presents Business Overview to Investors and Senior Biopharmaceutical Professionals at the BIO 2023 International ConventionGlobeNewsWire • 06/08/23
IMUNON Presents PlaCCine Preclinical Data at the 2023 Viruses and Cells – Gordon Research ConferenceGlobeNewsWire • 05/30/23
IMUNON Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/23
IMUNON to Hold First Quarter 2023 Financial Results and Business Update Conference Call on Thursday, May 11, 2023GlobeNewsWire • 05/04/23
IMUNON Presents Poster at the American Association for Cancer Research Annual Meeting Demonstrating Preclinical Immune Response of IMNN-001GlobeNewsWire • 04/19/23
IMUNON to Hold Fourth Quarter 2022 Financial Results and Business Update Conference Call on Thursday, March 30, 2023GlobeNewsWire • 03/23/23
IMUNON Announces Abstract Accepted for Presentation at the American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/15/23